Where does Fuso Pharmaceutical Industries, Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Fuso Pharmaceutical Industries, Ltd. ranks #8,592 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Fuso Pharmaceutical Industries, Ltd. hold?

Fuso Pharmaceutical Industries, Ltd. holds 37 US utility patents granted between 2015 and 2025, spanning 27 technology areas.

What is Fuso Pharmaceutical Industries, Ltd.'s Innovation Score?

Fuso Pharmaceutical Industries, Ltd. has an Innovation Score of 40.3 out of 100 (top 36% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Fuso Pharmaceutical Industries, Ltd. focus on?

Fuso Pharmaceutical Industries, Ltd.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 19 patents, ranking #1,031 of 6,058 assignees active in that subclass. Grants appear in 27 CPC subclasses total.

Is Fuso Pharmaceutical Industries, Ltd.'s patent grant rate increasing or decreasing?

Fuso Pharmaceutical Industries, Ltd.'s recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Fuso Pharmaceutical Industries, Ltd.'s patents?

Fuso Pharmaceutical Industries, Ltd.'s patents average 8.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Fuso Pharmaceutical Industries, Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Fuso Pharmaceutical Industries, Ltd.

USPTO PatentsView assignee record - 37 granted patents across 27 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Fuso ranks #8,592 of 49,997 tracked US assignees by granted-patent volume, with 37 patents across 27 technology areas.

#8,592
of 49,997 US assignees by volume: Top 36%
by Innovation Score (40.3/100): 8.2
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8592 · Foreign Corporation #8,592 · 37 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 37 grants
UPPER-Q #8,592/49,997
PHOTO-FINISH Fisher & Paykel…
CPC-FOCUS A61P · 27 areas
INNOV-PAR 40.3/100
CLAIMS-PAR 8.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Fisher & Paykel Appliances Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Fuso’s 40.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.6 pts (31%) Velocity 4.4 pts (11%) Breadth 18.4 pts (46%) Claim depth 4.9 pts (12%)

Qualcomm Incorporated · highest

85
Bizlink International · near

40
Fuso Pharmaceutical… · this assignee

40
Jilin Zhong Ying… · near

40
Movellus Circuits · near

40
Vatech Ewoo Holdings · near

40
3D Lighting… · lowest

7

What this shows Fuso's Innovation Score is 40.3/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Fuso?

Each dot is one of Fuso’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Fuso’s own 8.2 claims/patent is at or below the 16.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Fuso vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Fuso's grants concentrate

Fuso Pharmaceutical Industries, Ltd. is a focused PatentsView assignee: 27 CPC subclasses with 51.4% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (7 grants) versus a trough of 2 in 2019. By volume, Fuso sits between Flir Unmanned Aerial Systems ULC and Fraunhofer USA.

Fuso's three-year grant acceleration

Fuso Pharmaceutical Industries, Ltd. shows 8 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Flir Unmanned Aer…

37
Flow Control

37
Fortemedia

37
Fuji OIL Holdings

37
Fisher & Paykel A…

37
Flow International

37
Franklin Electric

37
Fraunhofer USA

37
Fuso Pharmaceutic… ◀

37

What this shows Fuso holds 37 patents at rank #8,588, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Fuso

By rank, the assignees closest to #8,588 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Fuso's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Fuso, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Fuso ranks #1,031 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (40 here).

Movellus Circuits Inc. 40 Vatech Ewoo Holdings Co., Ltd. 40 Jilin Zhong Ying High Technology Co., Ltd. 40 Bizlink International Corp. 40

Fuso's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Fuso Pharmaceutical Industries, Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	7	18.9%
2016	3	8.1%
2017	6	16.2%
2019	2	5.4%
2020	5	13.5%
2021	5	13.5%
2022	3	8.1%
2023	5	13.5%
2025partial year	1	2.7%

Which technologies does Fuso Pharmaceutical Industries, Ltd. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 19

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 16

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 12

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 10

C07K - Peptides 9

C07D - Heterocyclic Compounds 9

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 6

Y02A - Technologies FOR Adaptation TO Climate Change 6

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 5

C07C - Acyclic OR Carbocyclic Compounds 5

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 3

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 2

C08B - POLYSACCHARIDES; Derivatives Thereof 2

Y10T - Technical Subjects Covered BY Former US Classification 2

A61D - Veterinary Instruments, Implements, Tools, OR Methods 2

Top 15 of 27 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Fuso Pharmaceutical Industries, Ltd.'s patent record in context - here's where to go next.

Fuso Pharmaceutical Industries, Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 51.4% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #8,592 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Fuso Pharmaceutical Industries, Ltd. against Flir Unmanned Aerial Systems ULC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.